Overactive Bladder

Repeated Toxin Injections Safe and Effective for Refractory Overactive Bladder

December 26, 2011

Repeated injections of botulinum toxin type A (BoNTA) are safe and effective for the medium-term management of refractory overactive bladder (OAB) and idiopathic detrusor overactivity (IDO), according to British investigators.
 

Overactive Bladder Linked to Metabolic Syndrome in Women

November 01, 2011

Metabolic syndrome is associated with overactive bladder (OAB) in women, according to researchers.
 

Botulinum Toxin Effective in OAB Patients without Detrusor Overactivity

August 31, 2011

GLASGOW—Intravesical botulinum toxin may be an effective treatment for overactive bladder (OAB) without detrusor overactivity (DOA) on urodynamic assessment, researchers reported at the International Continence Society annual meeting.
 

Approval Sought for New Overactive Bladder Drug

August 29, 2011

If cleared by the FDA, mirabegron would be the first oral treatment with a new mechanism of action for OAB in almost 30 years.
 

Antibiotics May Improve Treatment of Overactive Bladder

August 29, 2011

GLASGOW—Antibiotics may be a useful adjunctive treatment for overactive bladder (OAB), according to British researchers.
 

Trigonal Injections of Botulinum Toxin Improve OAB Outcomes

May 18, 2011

WASHINGTON, D.C.—Trigonal intradetrusor injections of botulinum toxin-A (BTX-A) results in greater reduction in overactive bladder (OAB) symptoms compared with trigone-sparing BTX-A injections, Irish investigators reported at the American Urological Association 2011 annual meeting.
 

Overactive Bladder Often Associated with Pelvic Organ Prolapse

May 18, 2011

WASHINGTON, D.C.—Posterior compartment pelvic organ prolapse (POP) in women is often associated with overactive bladder (OAB), and POP surgery may help to decrease OAB symptoms as well as detrusor overactive (DO), according to study findings presented at the American Urological Association 2011 annual meeting.
 

Surrogate Markers May Identify Age-Associated Biochemical Changes in OAB patients

May 18, 2011

WASHINGTON, D.C.—Urinary nerve growth factor (NGF) and MCP-1 may be surrogate markers for monitoring age-associated biochemical changes in patients with overactive bladder (OAB), according to data presented at the American Urological Association 2011 annual meeting.
 

'OAB-Dry' May Need to be Reassessed

May 17, 2011

WASHINGTON, D.C.—Questionnaires used to diagnose patients with overactive bladder (OAB) may identify anyone with polyuria, bladder hypersensitivity, and even OAB-wet with rare leakage episodes as OAB-dry, investigators reported at the American Urological Association 2011 annual meeting.
 

Overactive Bladder Found in One Fifth of Type 2 Diabetics

May 17, 2011

WASHINGTON, D.C—Japanese researchers found that more than one fifth of patients with type 2 diabetes receiving care at a dedicated diabetes center have overactive bladder (OAB), and that the prevalence was more than twice as great among patients older than 50 and those who had diabetes for more than 10 years, according to data presented at the American Urological Association 2011 annual meeting.
 

Nocturia Is the Most Bothersome OAB Symptom in POTS Patients

May 17, 2011

WASHINGTON, D.C.—Nocturia is the most common overactive bladder (OAB) symptom affecting health-related quality of life (HRQL) in patients with postural tachycardia syndrome (POTS), investigators reported at the American Urological Association 2011 annual meeting.
 

Parkinson's Severity Associated with OAB Symptoms

May 17, 2011

WASHINGTON, D.C.—Overactive bladder (OAB) symptoms are common in patients with Parkinson's disease regardless of age and gender, and the severity of Parkinson's symptoms correlates with OAB symptoms, according to a study presented at the American Urological Association 2011 annual meeting.
 

OAB Symptoms Linked to Elevated Serum Leptin

May 16, 2011

WASHINGTON, D.C.—Elevation of serum leptin and a decrease in monocyte chemotactic protein-1 (MCP-1) levels are associated with overactive bladder (OAB) symptoms, according to new data presented at the American Urological Association 2011 annual meeting.
 

Sacral Neuromodulation Found Effective and Well-Tolerated

May 16, 2011

WASHINGTON, D.C.—Sacral neuromodulation with InterStim Therapy is safe and well tolerated as a treatment for patients with overactive bladder and those with urinary retention, French investigators reported at the American Urological Association 2011 annual meeting.
 

Adverse Events Common After Botulinum Toxin Injections

May 16, 2011

WASHINGTON, D.C.—Adverse events (AEs) after intravesical botulinum toxin type A for idiopathic detrusor overactivity (IDO) are encountered frequently, according to a new study presented at the American Urological Association 2011 annual meeting.
 

Ongoing Overactive Bladder Clinical Trials

 
 
 

Urinary Incontinence News

Older Age at RP Increases Urinary Incontinence Risk

Urinary Symptoms in Men Linked to Low Vitamin D

Pessary Trial May Detect Occult Stress Urinary Incontinence

Your Money


Your Practice

Consumer stocks do not lead the markets every year. During bull markets, investors often ignore consumer goods, which may seem dull compared to technology or finance. But over the long haul, consumer stocks tend to deliver competitive results.

Read more on
Conservative Investors, Consumer Companies in a Sluggish Economy

Renal Nutrition Update


Renal Nutrition Update

Research has shown that individuals who exercise have lower risk for chronic diseases than individuals who do not exercise.

Your Practice


Since its inception, health care providers have struggled with the need to protect patient privacy, share information, and keep paper work under control.

Read more on
Complying with HIPAA

Have any practice management topics that you'd like us to cover?
Let us know.
Popular Topics
Acute Kidney Injury Anemia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease CKD Diabetes Epidemiology Erectile Dysfunction Hemodialysis Hyperphosphatemia Hypertension Infection Kidney Cancer Kidney Stones Nutrition Overactive Bladder Peritoneal Dialysis Prostate Cancer PSA Reproductive Medicine Transplantation Urinary Incontinence UTI

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions